Back
Keros Therapeutics Quote, Financials, Valuation and Earnings
![](/images/offers/ims/large/offer6.jpg)
Jeff Bezos's Plan Exposed
And for investors who get in now profits could be massive - click here for full story.
Sell
25
KROS
Keros Therapeutics
Last Price:
45.28
Seasonality Move:
4.22%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer5.jpg)
The Next Nvidia?
Go here now for this breaking story.Keros Therapeutics Price Quote
$45.28
-0.37 (-0.81%)
(Updated: June 26, 2024 at 2:05 PM ET)
Keros Therapeutics Key Stats
Sell
25
Keros Therapeutics (KROS)
is a Sell
Day range:
$45.12 - $47.20
52-week range:
$27.02 - $73.00
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.63%
Volume:
245.7K
Avg. volume:
329.4K
1-year change:
10.05%
Market cap:
$1.6B
Revenue:
$151K
EPS:
$-5.15
How Much Does Keros Therapeutics Make?
Data Unavailable
Is Keros Therapeutics Growing As A Company?
Data Unavailable
Keros Therapeutics Stock Price Performance
-
Did Keros Therapeutics Stock Go Up Last Month?
Keros Therapeutics share price went down by -5.84% last month -
Did KROS's Share Price Rise Over The Last Year?
KROS share price rose by 10.05% over the past 1 year
What Is Keros Therapeutics 52-Week High & Low?
-
What Is Keros Therapeutics’s 52-Week High Share Price?
Keros Therapeutics has traded as high as $73.00 over the past 52 weeks -
What Is Keros Therapeutics’s 52-Week Low Share Price?
Keros Therapeutics has traded as low as $27.02 over the past 52 weeks
Keros Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Keros Therapeutics?
-
How Much Debt Does Keros Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Keros Therapeutics Have?
Cash and short term investments quarterly total is $442.4M -
What Is Keros Therapeutics’s Book Value Per Share?
Book value per share is 12.59
Is Keros Therapeutics Cash Flow Positive?
-
What Is KROS Cash Flow From Operations?
Cash flow from operations (TTM) is -$134.8M -
What Is Keros Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $228.1M -
What Is Keros Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.3M
Keros Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
KROS return on invested capital is -45.46% -
What Is Keros Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -41.68% -
What Is KROS Return On Equity?
ROE is a measure of profitability and is -45.46%
Keros Therapeutics Earnings Date & Stock Price
-
What Is Keros Therapeutics's Stock Price Today?
A single share of KROS can be purchased today for 45.65 -
What Is Keros Therapeutics’s Stock Symbol?
Keros Therapeutics trades on the nasdaq under the ticker symbol: KROS -
When Is Keros Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Keros Therapeutics is scheduled on August 7, 2024 -
When Is KROS's next ex-dividend date?
Keros Therapeutics's next ex-dividend date is June 26, 2024 -
How To Buy Keros Therapeutics Stock?
You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Keros Therapeutics Competitors
-
Who Are Keros Therapeutics's Competitors?
Below is a list of companies who compete with Keros Therapeutics or are related in some way:
Keros Therapeutics Dividend Yield
Data Unavailable
Keros Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 9.28% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 9 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 90.10 |
Upside from Last Price: | 97.37% |